Stéphane Mendras Email & Phone Number

Geneva, Ge, Ch

Geneva, Ge, Ch

Geneva

A San-Francisco based JV between Verily (Google Life Sciences) and Santen, harnessing the convergence of AI, microelectronics and scalable digital technologies to treat eye diseases.Products portfolio includes : - Smart contact lenses to treat presbyopia and enable controlled glaucoma drug release. - Connected smart dropper to significantly improve compliance/adherence to drop-based Rx treatment. - Innovative MGD treatment for dry-eye management. - And many more: https://twentytwenty.com/pipeline/RESPONSABILITY : - OUS strategy, business planning and roll-out. - Out-licensing initiative. ACHIEVEMENT : - Market Assessment & Prioritization (market potential, digital health maturity, access & funding, registration).- Regulatory Strategy under MDR for 15 different MedDev, incl. combination products (device/pharma).- Commercial roll-out across the Middle-East region (based on FDA registration).

Annecy, Auvergne-Rhône-Alpes, France

SaagHA is a company exclusively dedicated to the development, registration, promotion and commercialization of solutions made of bio-polymers and dedicated to ophthalmology & eye-care.HEALAFLOW IS THE FIRST PRODUCT OF SAAGHA : A slowly resorbable HA-based implant indicated for penetrating and non-penetrating glaucoma surgery.Injected under the scleral flap and the conjunctiva, it acts as a space-filler and efficiently limits the postoperative fibrosis thus improving the surgical success rate. HealaFlow is currently commercialized in 20+ countries.

Paris, Île-De-France, France

First European investment network of Business Angeles specialized in healthcare. ACTIVE INVESTOR & SUPPORTER :- A biotech company specialized in veterinary regenerative medicine that is leveraging the unique biological potential of neonatal stem cells to promote the harmonious healing of injuries or dampen inflammatory chronic diseases.- The all in one fertility platform - making the fertility journey effortless and empowering - being powered by AI, backed by science.- A biotech company with a unique approach in active personalized cancer immunotherapy, by harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens- Device company developing a unique patient monitoring solution, able to measure all vital signs, including blood pressure, in one device.- A regenerative medicine project that aims at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer.

Lille, Hauts-De-France, France

Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research.Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market.

Geneva, Switzerland

RESPONSABILITY : - Develop the surgical long-term strategy of Santen and drive products portfolio expansion. - Expand PRESERFLO MicroShunt commercialization beyond Europe. - Represent the Surgical Franchise within all corporate initiatives. ACHIEVEMENT : - Direct-sales expansion in UAE/KSA through the setup of a dedicated Dubai-based affiliate. - Indirect commercial expansion through distributors (Israel, South-Africa, Asia). - Strategic partnership with Glaukos for the Americas.** 2021 Santen President Club Winner (Special Award) **

Geneva Area, Switzerland

** Member of the EMEA Leadership Team **RESPONSABILITY : - Structure and develop an independent business-unit dedicated to surgical devices. - Support the integration of InnFocus Ltd. following its US$225m+ acquisition. - Build and develop a dedicated team to launch PRESERFLO MicroShunt across Europe. ACHIEVEMENT : - Established PRESERFLO MicroShunt as the preferred surgical option for advanced glaucoma patients' management.- Built & managed a dedicated team of Surgical Partners across Europe, with all necessary support functions (Medical Affairs, Market-Access, Marketing, Commercial Excellence). - Established the Surgical Division as the fastest-growing franchise (revenue & profit) within Santen.

Zürich Area, Switzerland

** Covidien (ex- Tyco Healthcare), acquired by Medtronic in 2015 **RESPONSABILITY : - Built the MITG Procedural Solutions Program & developed the franchise across EMEA.- Managed the MITG OEM Business-Unit.ACHIEVEMENT : - Established the Procedural Solution Offering for hernia, colorectal, bariatric and thoracic surgical procedures.- Commercial launch across 20+ countries (annuel revenue >US$50m).

Basingstoke (Uk)

** Member of the European Executive Leadership Team **RESPONSABILITY : - Develop opportunities for sales and margin growth by identifying and executing product sourcing, and channel outsourcing via strategic industry partnerships.- Manage the Covidien Custom Product Solutions division across Europe.- Represent Covidien Europe in large corporate projects (value-segments, M&A, assessment of new business segment).ACHIEVEMENT : - Extended Covidien Custom Product Solutions (CPS) presence into dental, pharma industry, medical devices, rehabilitation and surgical kit-packers market (annual revenue >US20m).- Licensed multiple new products for commercialization by Covidien Medical Supply under private-labels.

Geneva Area, Switzerland

** Co-Founder & Executive Committee Member / Anteis developed, manufactured and commercialized injectable medical devices made of hyaluronic acid (HA) dedicated to medical aesthetic, surgical ophthalmology and orthopedics **RESPONSABILITY : - Direct-sales management through affiliates in France and Germany- Evaluate market potential and feasibility towards additional direct market entry (Japan/Brazil) ACHIEVEMENT : - Implement and scale-up dedicated teams across affiliates (25+ people)- Established a JV in Japan, gaining 30% market-share in less than 3 years - Generate >20% of the total company revenue through direct sales

Geneva Area, Switzerland

RESPONSABILITY :- Fundraising- Strategic Partnership - B-to-B FranchiseACHIEVEMENT : - US$25m fundraised through 3 leading international VCs - Strategic collaboration with Merz Pharmaceuticals- Double-digit annual growth of the B2B franchise, through large partnerships (Sanofi-Aventis)** ACQUIRED BY MERZ PHARMA GROUP (TODAY MERZ AESTHETICS) **

Geneva Area, Switzerland

** Co-Founder / Development & commercialization of innovative surgical procedures & products for cataract surgery **RESPONSABILITY : - Product Development- Clinical & Regulatory Affairs- Supplier Management- Supply-Chain & Customer ServiceACHIEVEMENT : - Established new surgical concept for small incision cataract surgery (against induced astigmatism)- Quality System (ISO 13485/9001) & Products Registration in 40+ countries** ACQUIRED BY CROMA-PHARMA IN 2006 **

Ettlingen, Baden-Württemberg, Germany

** Surgical and contact lens care businesses spun-off from Allergan (2002). Today J&J Vision **RESPONSABILITY : - Support corporate strategic planning activities - Support M&A and Strategic Partnership initiatives

Mba

The Angels Santé Investor Training, Business Angels' Investment

Msc, Electronic Engineering

Activities and Societies: Member of the IEEE (Institute of Electrical and Electronics Engineers)

Education record